Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06205290 |
Title | A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | SWE | NOR | NLD | ITA | GBR | FRA | ESP | DEU | BEL | AUT |